Article information
Full text is only aviable in PDF
Bibliografía
[1.]
D.P. Rall, T.L. Loo, M. Lane, et al.
Appearance and persistence of fluorescence material in tumor tissue after tetracycline administration.
J Natl Cancer Inst, 19 (1957), pp. 79-84
[2.]
Rasmusen, D.S. Taxdall, D.S. Ward, F.H. Figge.
Fluorescence of human lynphatic and cancer tissues following high doses of intravenous hematoporphyrin.
Cancer, 8 (1955), pp. 78-81
[3.]
O. Raab.
Über die Wirkung fluoresciilender Stoffe auf Infusoria.
ZBiol, 39 (1900), pp. 524
[4.]
R.C. Mellors, A. Glassman, C.N. Pappanicolaou.
A microfluorometric scanning method for the detection of cancer cells in smears of exfoliated cells.
Cancer, 5 (1952), pp. 458-468
[5.]
S.H. Tomson, E.A. Emmett, S.H. Fox.
Photodestruction of mouse epithealial tumors after oral acridine orange and argon laser.
Cancer Res, 34 (1974), pp. 3.124-3.127
[6.]
N. Martini, mapping. Lung.
Symp Advances in Bronchoscopy, ACCP.
March 17-19. S. Diego California, (1983),
[7.]
N. Martini, M.R. Melaned.
Occult carcinoma of the lungs.
Ann Thorac Surg, 30 (1980), pp. 215-223
[8.]
M.R. Molaned, B.J. Flehinger, B.Z. Muhammad, R.T. Heeland, E.T. Hallerman, N. Martini.
Detection of true pathology stage I lung cancer in a screening program and the effect on survival.
Cancer, 47 (1981), pp. 1.182-1.187
[9.]
D.E. Williamns, P.C. Pairolero, C.S. Davis, et al.
Survival of patients surgically treated for stage I lung cancer.
J Thor Cardiovasc Surg, 82 (1981), pp. 70-76
[10.]
D.R. Sanderson, R.S. Fontana, L.B. Woolner, P.E. Bernatz, W.S. Payne.
Bronchoscopic localization of radiographically occult lung cancer.
Chest, 65 (1974), pp. 608-612
[11.]
N. Martini, E.J. Beatt, E.E. Clifton, M.R. Melaned.
Radiologically occult lung cancer.
Report of 26 cases Surg Clin North Amer, 54 (1974), pp. 811-823
[12.]
D.R. Sanderson, R.S. Fontana.
Early lung cancer detection and localization.
Ann Otol, 84 (1975), pp. 583-588
[13.]
M.R. Melaned, B.J. Flehhiner, B. Muhammad, R.T. Zaman Helan, W.A. Perchick, N. Martini.
Screening for early lung cancer. Result of the Memorial Sloan Kettering Study in New York.
Chest, 1 (1984), pp. 44-53
[14.]
L.B. Woolner, R.S. Fontana, D.A. Cortese, et al.
Roentgenographically occult lunch cancer: pathologic findings and frecuency of multicentricity during a ten year period.
Mayo Clinic Proc, 59 (1984), pp. 453-456
[15.]
D.A. Cortese, P.C. Pairolero, M.H. Bergstraldh, et al.
Roentgenographycally occult lung cáncer. A ten year experience.
J Thorac Cardiovasc Surg, 86 (1983), pp. 373-380
[16.]
D.A. Córtese, J.H. Kinsey.
Hematoporphyrin derivative fluorescence for lung cancer localization.
Semin Respir Med, 3 (1981), pp. 37-41
[17.]
G. Saccomano, V.E. Archer, O. Auerbach, R.P. Saunders, L.M. Brennan.
Development of carcinoma of the lung as reflected in exfoliated cells.
Cancer, 33 (1974), pp. 256-270
[18.]
B.R. Marsch, J.K. Frost, Y.S. Erizan, D. Carter, D.F. Proctor.
Flexible fiberoptic bronchoscopy Its place in the search for lung cancer.
Ann Otol Rhinol Laryngol, 82 (1973), pp. 757-764
[19.]
R.L. Lipson, E.J. Baldes.
The photodynamic properties of a particular hematoporphyrin derivate.
Arch Dermatol, 82 (1960), pp. 508-516
[20.]
R.L. Lipson, E.J. Baldes, A.M. Olsen.
The use of a derivative of hematoporphyrin in tumor detection.
J Natl Cancer Inst, 26 (1961), pp. 1-10
[21.]
R.L. Lipson, E.J. Baldes, A.M. Olsen.
Hematoporphyrin derivative: a new aid for endoscopio detection of malignant disease.
J Cardiovasc Surg, 42 (1961), pp. 623-629
[22.]
R.L. Lipson, E.J. Baldes, M.J. Gray.
Hematoporphyrin derívate for detection and management of cancer.
Cancer, 20 (1967), pp. 2.255-2.267
[23.]
M.C. Berembaun, R. Bonnet, P.A. Sourides.
In vivo biological activity of componente of hematoporphyrin derivative.
Br J Cancer, 45 (1982), pp. 571-581
[24.]
T.J. Douquerty, D.G. Boyle, K.R. Weishaup, et al.
Photoradiation therapy. Clinical and drugs advances.
Adv Exp Med Biol, 160 (1983), pp. 3
[25.]
C.J. Gomer, T.J. Dougquerty.
Determination of H3 and C14 hematoporphyrin derivative distribution in malignant and normal tissues.
Cancer Res, 39 (1979), pp. 146
[26.]
P.J. Bugelsky, C.W. Porter, T.C. Dougherty.
Autoradiografic distribution of hematoporphyrin in normal and tumor tissues of the mouse.
Cancer Res, 41 (1981), pp. 4.606-4.612
[27.]
T.J. Douquerty, K.R. Weishaupt, D.G. Boyle.
Cancer. Principles and practice on Oncology, pp. 1.836
[28.]
W. Hausmann.
Über die sensibilieriserenden Wirkung tierischer Farbstoffe und ihre physiologische Bedeutung.
Biochem Z, 14 (1908), pp. 275
[29.]
F. Meyer-Betz.
Untersunchungen über die biologische (photodynamische) Wirkung der hamatoporphyrins und underer Derivate der Blut und Gallenfarbstoffe.
Dtsch Arch Klin Med, 112 (1913), pp. 476-503
[30.]
H. Auler, G. Banzer.
Untersunchugen über die Rolle der Porphyrie bei gaschwulsskranken Menschen und.
Tieren Z Krebsforsch, 53 (1943), pp. 65-68
[31.]
F.H.G. Figge, G.S. Weiland, L.O.J. Manganiello.
Cancer detection and therapy: Affinity of neoplastic, ambrionic and traumatized tissues for porphyrins and metalloporphyrins.
Proc Soc Exp Biol Med, 68 (1948), pp. 640-641
[32.]
R.J. Carpenter III, H.B. Neel III, R.J. Ryan, D.R. Sanderson.
Tumor fluorescence with hematoporphyrin derivative.
Ann Otol Rhinol Laryngol, 86 (1977), pp. 661-666
[33.]
D.A. Cortese, J.H. Kinsey.
Endoscopic management of lung cancer with hematoporphyrin derivative phototherapy.
Mayo Clin Proc, 57 (1982), pp. 543-547
[34.]
Y. Hayata, H. Kato, C. Konaka, et al.
Photoradiation therapy with hematoporphyrin derivative in early and stage I lung cancer.
Chest, 86 (1984), pp. 169-177
[35.]
D.A. Córtese, J.H. Kinsey.
Hematoporphyrin derivative phototherapy in the treatment of the bronchogenic carcinoma.
Chest, 86 (1984), pp. 8-13
[36.]
O.J. Balchum, D.R. Doiron.
Photoradiation therapy of endobronchial lung cancer Large obstructing tumors and early stage bronchial cancer lesions.
Clin Chest Med, 6 (1985), pp. 255-275
[37.]
E.S. Edell, D.A. Cortese.
Broncoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: a 5-year experience.
Mayo Clin Proc, 62 (1987), pp. 8-14
[38.]
H. Kato, C. Konaka, N. Kawatw, et al.
Five year disease free survival of a lung cancer patient treated only by photodynamic therapy.
Chest, 90 (1986), pp. 768-770
[39.]
J.S. Me Caughan, T.A. Nims, J.T. Guy, W.J. Hicks, T.E. Williams, L.R. Laufman.
Photodynamic therapy for esophageal tumors.
Arch Surg, 124 (1989), pp. 74-80
[40.]
J.P. Díaz Jiménez, E.S. Edell.
Fotoquimioterapia. Utilidad de la hematoporfirina en el tratamiento del cáncer por fotorradiación.
Rev Clin Esp, 182 (1988), pp. 34-38
[41.]
J.P. Díaz Jiménez, E.S. Edell, D.A. Cortese.
Time dependence on cell survival after hematoporphyrin derivative phototherapy.
Abstract of the Porphyrin Photosensitization Workshop. Los Angeles California June, (1986), pp. 11
[42.]
M. Paramsothy, J. Zainuddin, K.S. Low.
In vivo nuclear imaging studies of uptake and retention of Tc-99m-labelled HpD in a murine tumor.
Laser Med Sci, 4 (1989), pp. 205-210
[43.]
E.S. Edell, D.A. Cortese.
Potentation of hematoporphyrin derivate phototherapy with adriamycin.
Abstracts of the orphyrin Photosensitization Workshop. Los Angeles California June, (1986), pp. 15
[44.]
B.W. Henderson, T.J. Dougherty, P.B. Malone.
Studies of the mechanisms of tumor destruction by photoradiation therapy.
Prog Clin Biol Res, 170 (1984), pp. 601-612
[45.]
W. Matthews, W. Rizzoni, J. Mitchell, A. Russo, H. Pass.
In vitro photodynamic therapy human lung cancer.
J Surg Res, 47 (1989), pp. 276-281
[46.]
M.J. Gray, L. Lipson, J.V.S. Maeck, L. Parker, D. Romeyn.
Use of hematoporphyrin derivative in detection and management of cervical cancer: A-preliminary report.
A J Obstet Gynecol, 99 (1967), pp. 766-771
[47.]
R.L. Lipson, E.J. Baldes, A.M. Olsen.
Further evaluation of the use of hematoporphyrin derivative as a new aid for the endoscopio detection of malignant disease.
Chest, 46 (1964), pp. 676-679
[48.]
J.R. Leonard, W.L. Beck.
Hematoporphyrin fluorescence: An aid in diagnosis of maíignant neoplasms.
Laryngoscope, 81 (1971), pp. 365-372
[49.]
A.E. Profic, D.R. Doiron.
Laser fluorescence bronchoscopy for localization of occult lung tumors.
Med Phys, 6 (1979), pp. 523-525
[50.]
D.R. Doiron, A.E. Profio, R.J. Vincent, T.J. Dougherty.
Fluorescence bronchoscopy for detection of lung cancer.
Chest, 76 (1979), pp. 27-32
[51.]
O.J. Balcum, D.R. Doiron, A.E. Profio, G.C. Huth.
Fluorescence bronchoscopy for localizing early bronchial cancer and carcinoma in situ.
Recent Results Cancer Res, 82 (1982), pp. 97-120
[52.]
A.E. Profio, D.R. Doiron, O.J. Balchum, G.C. Huth.
Fluorescence bronchoscopy for localization of carcinoma in situ.
Med Phys, 10 (1983), pp. 35-39
[53.]
J.H. Kinsey, D.A. Cortese, D.R. Sanderson.
Detection of hematoporphyrin fluorescence during fiberoptic bronchoscopy to localize early bronchogenic carcinoma.
Mayo Clin Proc, 53 (1978), pp. 594-600
[54.]
D.A. Córtese, J.H. Kinsey, L.B. Woolner, D.R. Sanderson, R.S. Fontana.
Hematoporphyrin derivative in the detection and localization of radiographically occult lung cancer.
Am Rev Respir Dis, 126 (1982), pp. 1.087-1.088
[55.]
Y. Hayata, H. Kato, C. Honaka, et al.
Fiberoptic bronchoscopic photoradiation in experimentally induced canine lung cancer.
Cancer, 51 (1983), pp. 50-56
[56.]
H. Kato, D.A. Cortese.
Early detection of lung cancer by means of hematoporphyrin derivative fluorescence and laser photoradiation.
Clin Chest Med, 6 (1985), pp. 237-253
[58.]
M. Kreimer-Birnbaum.
Modified porphyrins clorins, pthalocyanines, and purpurins: Second generation photosensitizers for photodynamic therapy.
Semin Hematol, 26 (1989), pp. 157-173
[59.]
A.R. Morgan, S.H. Selman.
New photosensitizers for the photodynamic therapy of tumors.
Drugs of the Future, 13 (1988), pp. 1.073-1.082
Copyright © 1991. Sociedad Española de Neumología y Cirugía Torácica
